Skip to content

Sensitization to lupine flour: is it clinically relevant?

Sensitization to lupine flour: is it clinically relevant? - allergy to lupine flour

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29872
Enrollment
10
Registered
2006-11-21
Start date
2006-12-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food allergy IgE mediated food allergy

Interventions

Patients will be asked to undergo DBPCFC. They will intake lupine flour that is hidden in small cookies. It may be possible that lupine flour is not a part of the diet of the patient and in that cas

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a possible food allergy (complaints after intake of certain food) and a positieve skin test (HEP (Histamine Equivalent Prick test) index > 0.15) with lupine flour - and peanut extract. Older than 18 years

Exclusion criteria

Exclusion criteria: pregnancy, inability to stop anti histamines, using medication affecting provocation: e.g. prednison, cyclosporine, montelukast

Design outcomes

Primary

MeasureTime frame
Skin tests with lupine flour, peanut and soy. Reactions on DBPCFC's. Presence of specific IgE against lupine flour in the serum of the patient.

Secondary

MeasureTime frame
Presence of cross - reacting allergenes.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)